342 related articles for article (PubMed ID: 21494075)
21. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.
Liu X; Hamnvik OP; Chamberland JP; Petrou M; Gong H; Christophi CA; Christiani DC; Kales SN; Mantzoros CS
Metabolism; 2014 Jun; 63(6):773-82. PubMed ID: 24726813
[TBL] [Abstract][Full Text] [Related]
22. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.
Kang YH; Min HK; Son SM; Kim IJ; Kim YK
Diabetes Res Clin Pract; 2007 Aug; 77(2):306-13. PubMed ID: 17353063
[TBL] [Abstract][Full Text] [Related]
23. The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.
Qiu J; Kuang M; Yang R; Yu C; He S; Sheng G; Zou Y
Front Endocrinol (Lausanne); 2023; 14():1239398. PubMed ID: 37727457
[TBL] [Abstract][Full Text] [Related]
24. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.
Kim DJ; Noh JH; Cho NH; Lee BW; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
Diabet Med; 2005 Sep; 22(9):1134-40. PubMed ID: 16108838
[TBL] [Abstract][Full Text] [Related]
25. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers.
Sesti G; Fiorentino TV; Hribal ML; Sciacqua A; Perticone F
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1182-7. PubMed ID: 23419734
[TBL] [Abstract][Full Text] [Related]
26. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
[TBL] [Abstract][Full Text] [Related]
27. Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease.
Ma Q; Liao X; Shao C; Lin Y; Wu T; Sun Y; Feng ST; Ye J; Zhong B
BMC Gastroenterol; 2021 May; 21(1):215. PubMed ID: 33971815
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
[TBL] [Abstract][Full Text] [Related]
29. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients.
Zelle DM; Corpeleijn E; van Ree RM; Stolk RP; van der Veer E; Gans RO; Homan van der Heide JJ; Navis G; Bakker SJ
Am J Transplant; 2010 Jan; 10(1):106-14. PubMed ID: 19951280
[TBL] [Abstract][Full Text] [Related]
30. Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.
Khedmat H; Fallahian F; Abolghasemi H; Hajibeigi B; Attarchi Z; Alaeddini F; Holisaz MT; Pourali M; Sharifi S; Zarei N
World J Gastroenterol; 2007 Feb; 13(6):889-94. PubMed ID: 17352018
[TBL] [Abstract][Full Text] [Related]
31. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease.
Razavizade M; Jamali R; Arj A; Talari H
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):513-20. PubMed ID: 23060397
[TBL] [Abstract][Full Text] [Related]
32. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.
Fraser A; Harris R; Sattar N; Ebrahim S; Davey Smith G; Lawlor DA
Diabetes Care; 2009 Apr; 32(4):741-50. PubMed ID: 19131466
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
[TBL] [Abstract][Full Text] [Related]
34. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults.
Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR
Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318
[TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study.
Jarcuska P; Janicko M; Drazilová S; Senajová G; Veselíny E; Fedacko J; Siegfried L; Kristian P; Tkác M; Pella D; Mareková M; Gecková AM; Jarcuska P;
Cent Eur J Public Health; 2014 Mar; 22 Suppl():S43-50. PubMed ID: 24847614
[TBL] [Abstract][Full Text] [Related]
36. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
Zhu FS; Liu S; Chen XM; Huang ZG; Zhang DW
World J Gastroenterol; 2008 Nov; 14(41):6395-400. PubMed ID: 19009658
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.
Bulum T; Kolarić B; Duvnjak L; Duvnjak M
Dig Dis Sci; 2011 Dec; 56(12):3655-63. PubMed ID: 21735081
[TBL] [Abstract][Full Text] [Related]
38. Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey.
Kasapoglu B; Turkay C; Bayram Y; Koca C
Indian J Med Res; 2010 Jul; 132():56-61. PubMed ID: 20693590
[TBL] [Abstract][Full Text] [Related]
39. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
